POINT Biopharma and TerraPower Sign Supply Agreement for Actinium-225
TORONTO, March 23, 2021 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, and TerraPower, a leading nuclear innovation company that …